Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin A E Carr

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|July 19, 2005
Fragment-based lead discovery: leads by designRobin A E Carr, Miles Congreve, Christopher W Murray, et al.
Journal of Medicinal Chemistry|February 24, 2007
Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretaseMiles Congreve, David Aharony, Jeffrey Albert, et al.
Journal of Medicinal Chemistry|January 22, 2005
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generationAdrian L Gill, Martyn Frederickson, Anne Cleasby, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|July 19, 2005
Fragment-based lead discovery: leads by designRobin A E Carr, Miles Congreve, Christopher W Murray, et al.
Journal of Medicinal Chemistry|February 24, 2007
Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of beta-secretaseMiles Congreve, David Aharony, Jeffrey Albert, et al.
Journal of Medicinal Chemistry|January 22, 2005
Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generationAdrian L Gill, Martyn Frederickson, Anne Cleasby, et al.
Pageof 1